Equities research analysts forecast that Teladoc Health Inc (NYSE:TDOC) will report earnings of ($0.35) per share for the current fiscal quarter, according to Zacks Investment Research. Ten analysts have issued estimates for Teladoc Health’s earnings, with the lowest EPS estimate coming in at ($0.40) and the highest estimate coming in at ($0.22). Teladoc Health reported earnings per share of ($0.50) during the same quarter last year, which would indicate a positive year-over-year growth rate of 30%. The firm is expected to issue its next quarterly earnings results on Tuesday, February 26th.
On average, analysts expect that Teladoc Health will report full year earnings of ($1.47) per share for the current financial year, with EPS estimates ranging from ($1.52) to ($1.33). For the next financial year, analysts forecast that the firm will report earnings of ($1.06) per share, with EPS estimates ranging from ($1.40) to ($0.60). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that follow Teladoc Health.
Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Thursday, November 1st. The health services provider reported ($0.34) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.02. Teladoc Health had a negative net margin of 31.32% and a negative return on equity of 14.05%. The business had revenue of $111.00 million for the quarter, compared to analyst estimates of $109.94 million. During the same period in the previous year, the business posted ($0.55) earnings per share. The business’s revenue was up 61.6% compared to the same quarter last year.
In other Teladoc Health news, CEO Jason N. Gorevic sold 25,000 shares of the company’s stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $75.05, for a total value of $1,876,250.00. Following the sale, the chief executive officer now owns 536,184 shares of the company’s stock, valued at $40,240,609.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jason N. Gorevic sold 35,000 shares of the company’s stock in a transaction dated Monday, November 19th. The shares were sold at an average price of $54.80, for a total transaction of $1,918,000.00. Following the completion of the sale, the chief executive officer now directly owns 541,184 shares in the company, valued at approximately $29,656,883.20. The disclosure for this sale can be found here. Insiders have sold 255,929 shares of company stock worth $17,683,623 over the last 90 days. 3.95% of the stock is currently owned by company insiders.
Several hedge funds and other institutional investors have recently made changes to their positions in TDOC. Harvest Fund Management Co. Ltd purchased a new stake in shares of Teladoc Health in the third quarter valued at about $165,000. Signaturefd LLC purchased a new stake in shares of Teladoc Health in the third quarter valued at about $173,000. Aperio Group LLC purchased a new stake in shares of Teladoc Health in the second quarter valued at about $201,000. California Public Employees Retirement System purchased a new stake in shares of Teladoc Health in the second quarter valued at about $203,000. Finally, Biondo Investment Advisors LLC purchased a new stake in shares of Teladoc Health in the second quarter valued at about $205,000.
Shares of Teladoc Health stock traded down $2.40 on Monday, reaching $53.41. 2,297,902 shares of the stock were exchanged, compared to its average volume of 1,497,695. Teladoc Health has a 1-year low of $30.88 and a 1-year high of $89.05. The company has a quick ratio of 8.99, a current ratio of 8.99 and a debt-to-equity ratio of 0.40. The firm has a market cap of $3.91 billion, a price-to-earnings ratio of -32.37 and a beta of 0.92.
Teladoc Health Company Profile
Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Further Reading: What Does Beta Mean In Stock Selection
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.